| Management of hepatitis B in China F Lu, H Zhuang Chinese medical journal 122 (1), 3-4, 2009 | 713 | 2009 |
| SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 Y Wang, S Liu, H Liu, W Li, F Lin, L Jiang, X Li, P Xu, L Zhang, L Zhao, ... Journal of hepatology 73 (4), 807-816, 2020 | 702 | 2020 |
| Electrospun water-soluble carboxyethyl chitosan/poly (vinyl alcohol) nanofibrous membrane as potential wound dressing for skin regeneration Y Zhou, D Yang, X Chen, Q Xu, F Lu, J Nie Biomacromolecules 9 (1), 349-354, 2008 | 545 | 2008 |
| Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound J Wang, T Shen, X Huang, GR Kumar, X Chen, Z Zeng, R Zhang, R Chen, ... Journal of hepatology 65 (4), 700-710, 2016 | 491 | 2016 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 446 | 2019 |
| An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene F Lu, AB Gladden, JA Diehl Cancer research 63 (21), 7056-7061, 2003 | 307 | 2003 |
| Guideline of prevention and treatment for chronic hepatitis B (2015 update) J Hou, G Wang, F Wang, J Cheng, H Ren, H Zhuang, J Sun, L Li, J Li, ... Journal of clinical and translational hepatology 5 (4), 297, 2017 | 232 | 2017 |
| Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia GW Guan, L Gao, JW Wang, XJ Wen, TH Mao, SW Peng, T Zhang, ... Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal …, 2020 | 228 | 2020 |
| Long-term functional maintenance of primary human hepatocytes in vitro C Xiang, Y Du, G Meng, L Soon Yi, S Sun, N Song, X Zhang, Y Xiao, ... Science 364 (6438), 399-402, 2019 | 183 | 2019 |
| Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma J Zhang, J Cheng, Z Zeng, Y Wang, X Li, Q Xie, J Jia, Y Yan, Z Guo, J Gao, ... Oncotarget 6 (39), 42040, 2015 | 182 | 2015 |
| 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit W Zhao, L Wang, H Han, K Jin, N Lin, T Guo, Y Chen, H Cheng, F Lu, ... Cancer cell 23 (4), 541-556, 2013 | 181 | 2013 |
| Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos (t … R Fan, J Sun, Q Yuan, Q Xie, X Bai, Q Ning, J Cheng, Y Yu, J Niu, G Shi, ... Gut 65 (2), 313-320, 2016 | 179 | 2016 |
| Transmission of hepatitis E virus from rabbits to cynomolgus macaques P Liu, QN Bu, L Wang, J Han, RJ Du, YX Lei, YQ Ouyang, J Li, YH Zhu, ... Emerging infectious diseases 19 (4), 559, 2013 | 167 | 2013 |
| Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex‐determining region Y box 6 in hepatocellular carcinoma Q Xie, X Chen, F Lu, T Zhang, M Hao, Y Wang, J Zhao, MA McCrae, ... Cancer 118 (9), 2431-2442, 2012 | 165 | 2012 |
| Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 S Benzeno, F Lu, M Guo, O Barbash, F Zhang, JG Herman, PS Klein, ... Oncogene 25 (47), 6291-6303, 2006 | 162 | 2006 |
| Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer O Barbash, P Zamfirova, DI Lin, X Chen, K Yang, H Nakagawa, F Lu, ... Cancer cell 14 (1), 68-78, 2008 | 158 | 2008 |
| SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma Y Jia, Y Yang, S Liu, S Liu, JG Herman, F Lu, M Guo Epigenetics 5 (8), 743-749, 2010 | 155 | 2010 |
| Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5 JC Zhang, K Claffey, R Sakthivel, Z Darzynkiewicz, DE Shaw, J Leal, ... The FASEB Journal 14 (15), 2589-2600, 2000 | 152 | 2000 |
| Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication J Wang, ZW Xu, S Liu, RY Zhang, SL Ding, XM Xie, L Long, XM Chen, ... World journal of gastroenterology: WJG 21 (32), 9554, 2015 | 134 | 2015 |
| Persistent low level of hepatitis B virus promotes fibrosis progression during therapy Y Sun, X Wu, J Zhou, T Meng, B Wang, S Chen, H Liu, T Wang, X Zhao, ... Clinical Gastroenterology and Hepatology 18 (11), 2582-2591. e6, 2020 | 128 | 2020 |
